Christian F. Krebs

Christian F. Krebs

Auto-generated profile, based on publicly available information

Christian F. Krebs

III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in Immunity
Verified
Journal Article
Closed access
MSMichel Seman
Michel Seman
SASahil Adriouch
Sahil Adriouch
FSFelix Scheuplein
Felix Scheuplein
CKChristian Krebs
Christian Krebs
DFDunja Freese
Dunja Freese
FKFriedrich Koch-Nolte
Friedrich Koch-Nolte

1 November 2016 in Immunity
Verified
Journal Article
Open access
CKChristian F. Krebs
Christian F. Krebs
HPHans-Joachim Paust
Hans-Joachim Paust
SKSonja Krohn
Sonja Krohn
TKTobias Koyro
Tobias Koyro
SBSilke R. Brix
Silke R. Brix
UPUlf Panzer
Ulf Panzer
Th17 cells are most abundant in the gut, where their presence depends on the intestinal microbiota. Here, we examined whether intestinal Th17 cells contribute to extra-intestinal Th17 responses in autoimmune kidney disease. We found high frequencies of Th17 cells in the kidneys of patients with antineutrophil cytoplasmatic antibody (ANCA)-associated glomerulonephritis. We utilized photoconversion of intestinal cells in Kaede mice to track intestinal T cell mobilization upon glomerulonephritis induction, and we found that Th17 cells egress from the gut in a S1P-receptor-1-dependent fashion and subsequently migrate to the kidney via the CCL20/CCR6 axis. Depletion of intestinal Th17 cells in germ-free and antibiotic-treated mice ameliorated renal disease, whereas expansion of these cells upon Citrobacter rodentium infection exacerbated pathology. Thus, in some autoimmune settings, intestinal Th17 cells migrate into target organs, where they contribute to pathology. Targeting the intestinal Th17 cell "reservoir" may present a therapeutic strategy for these autoimmune disorders.

1 March 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
UWUlrich Wenzel
Ulrich Wenzel
JTJan Eric Turner
Jan Eric Turner
CKChristian Krebs
Christian Krebs
CKChristian Kurts
Christian Kurts
DHDavid G. Harrison
David G. Harrison
HEHeimo Ehmke
Heimo Ehmke
Traditionally, arterial hypertension and subsequent end-organ damage have been attributed to hemodynamic factors, but increasing evidence indicates that inflammation also contributes to the deleterious consequences of this disease. The immune system has evolved to prevent invasion of foreign organisms and to promote tissue healing after injury. However, this beneficial activity comes at a cost of collateral damage when the immune system overreacts to internal injury, such as prehypertension. Renal inflammation results in injury and impaired urinary sodium excretion, and vascular inflammation leads to endothelial dysfunction, increased vascular resistance, and arterial remodeling and stiffening. Notably, modulation of the immune response can reduce the severity of BP elevation and hypertensive end-organ damage in several animal models. Indeed, recent studies have improved our understanding of how the immune response affects the pathogenesis of arterial hypertension, but the remarkable advances in basic immunology made during the last few years still await translation to the field of hypertension. This review briefly summarizes recent advances in immunity and hypertension as well as hypertensive end-organ damage.

12 February 2021 in Science Immunology
Verified
Journal Article
Open access
PDF file
YZYu Zhao
Yu Zhao
CKChristoph Kilian
Christoph Kilian
JTJan-Eric Turner
Jan-Eric Turner
LBLidia Bosurgi
Lidia Bosurgi
KRKevin Roedl
Kevin Roedl
CKChristian F. Krebs
Christian F. Krebs
Tissue-resident memory-like T H 17 cells are clonally expanded in bronchoalveolar lavage fluid of patients with severe COVID-19.

1 June 2019 in Cell Reports
Verified
Journal Article
Open access
LTLikai Tan
Likai Tan
ISInga Sandrock
Inga Sandrock
IOIvan Odak
Ivan Odak
YAYuval Aizenbud
Yuval Aizenbud
AWAnneke Wilharm
Anneke Wilharm
SRSarina Ravens
Sarina Ravens
IL-17-producing γδ T cells express oligoclonal Vγ4+ and Vγ6+ TCRs, mainly develop in the prenatal thymus, and later persist as long-lived self-renewing cells in all kinds of tissues. However, their exchange between tissues and the mechanisms of their tissue-specific adaptation remain poorly understood. Here, single-cell RNA-seq profiling identifies IL-17-producing Vγ6+ T cells as a highly homogeneous Scart1+ population in contrast to their Scart2+ IL-17-producing Vγ4+ T cell counterparts. Parabiosis demonstrates that Vγ6+ T cells are fairly tissue resident in the thymus, peripheral lymph nodes, and skin. There, Scart1+ Vγ6+ T cells display tissue-specific gene expression signatures in the skin, characterized by steady-state production of the cytokines IL-17A and amphiregulin as well as by high expression of the anti-apoptotic Bcl2a1 protein family. Together, this study demonstrates how Scart1+ Vγ6+ T cells undergo tissue-specific functional adaptation to persist as effector cells in their skin habitat.

21 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LBLeonie Brockmann
Leonie Brockmann
SSShiwa Soukou
Shiwa Soukou
BSBabett Steglich
Babett Steglich
PCPaulo Czarnewski
Paulo Czarnewski
LZLilan Zhao
Lilan Zhao
Samuel HuberSamuel Huber
Samuel Huber
IL-10 is a prototypical anti-inflammatory cytokine, which is fundamental to the maintenance of immune homeostasis, especially in the intestine. There is an assumption that cells producing IL-10 have an immunoregulatory function. However, here we report that IL-10-producing CD4+ T cells are phenotypically and functionally heterogeneous. By combining single cell transcriptome and functional analyses, we identified a subpopulation of IL-10-producing Foxp3neg CD4+ T cells that displays regulatory activity unlike other IL-10-producing CD4+ T cells, which are unexpectedly pro-inflammatory. The combinatorial expression of co-inhibitory receptors is sufficient to discriminate IL-10-producing CD4+ T cells with regulatory function from others and to identify them across different tissues and disease models in mice and humans. These regulatory IL-10-producing Foxp3neg CD4+ T cells have a unique transcriptional program, which goes beyond the regulation of IL-10 expression. Finally, we found that patients with Inflammatory Bowel Disease demonstrate a deficiency in this specific regulatory T-cell subpopulation.